Susquehanna International Group
CDLX icon

Susquehanna International Group’s Cardlytics CDLX Stock Holding History

Susquehanna International Group’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$603K Buy
134,200
+123,870
+1,199% +$926K ﹤0.01% 9461
2026
Q1 		$108K Sell
10,330
-4,010
-28% -$39.1K ﹤0.01% 12287
2025
Q4 		$165K Sell
14,340
-3,180
-18% -$49.1K ﹤0.01% 11073
2025
Q3 		$426K Buy
17,520
+14,320
+448% +$239K ﹤0.01% 9332
2025
Q2 		$52.8K Sell
3,200
-4,950
-61% -$85.5K ﹤0.01% 12092
2025
Q1 		$148K Buy
8,150
+1,540
+23% +$44K ﹤0.01% 11242
2024
Q4 		$245K Sell
6,610
-4,310
-39% -$165K ﹤0.01% 10259
2024
Q3 		$349K Sell
10,920
-6,230
-36% -$346K ﹤0.01% 9272
2024
Q2 		$1.41M Sell
17,150
-14,110
-45% -$1.53M ﹤0.01% 5809
2024
Q1 		$4.53M Buy
31,260
+18,680
+148% +$1.58M ﹤0.01% 3780
2023
Q4 		$1.16M Sell
12,580
-5,740
-31% -$584K ﹤0.01% 6621
2023
Q3 		$3.02M Buy
18,320
+13,540
+283% +$1.76M ﹤0.01% 4373
2023
Q2 		$302K Buy
4,780
+1,850
+63% +$112K ﹤0.01% 9419
2023
Q1 		$99.6K Buy
2,930
+230
+9% +$12K ﹤0.01% 11304
2022
Q4 		$156K Sell
2,700
-1,760
-39% -$109K ﹤0.01% 10450
2022
Q3 		$419K Buy
+4,460
New +$635K ﹤0.01% 8944
2022
Q2 		– Sell
-2,510
Closed -$1.38M – 12965
2022
Q1 		$1.38M Buy
2,510
+2,040
+434% +$1.23M ﹤0.01% 6351
2021
Q4 		$311K Sell
470
-5,080
-92% -$3.88M ﹤0.01% 10406
2021
Q3 		$4.66M Buy
5,550
+3,340
+151% +$3.39M ﹤0.01% 4080
2021
Q2 		$2.81M Buy
2,210
+1,650
+295% +$1.86M ﹤0.01% 5173
2021
Q1 		$614K Sell
560
-1,020
-65% -$1.35M ﹤0.01% 8999
2020
Q4 		$2.26M Sell
1,580
-120
-7% -$128K ﹤0.01% 4837
2020
Q3 		$1.2M Sell
1,700
-230
-12% -$167K ﹤0.01% 5676
2020
Q2 		$1.35M Sell
1,930
-690
-26% -$398K ﹤0.01% 5240
2020
Q1 		$916K Buy
2,620
+1,380
+111% +$977K ﹤0.01% 5609
2019
Q4 		$779K Buy
+1,240
New +$606K ﹤0.01% 6019

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.88B AUM 2.5% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $620M AUM 14.15% 1-Year Est. Return
WPM
Worldly Partners Management Needham, Massachusetts $122M AUM 11.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.41B AUM 39.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $2.16B AUM 28.56% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Susquehanna International Group's CDLX Position: Q2 2026 in Review

Susquehanna International Group sold out of Cardlytics (CDLX) in Q2 2026, closing a stake of 1,592 shares — an estimated $11.9K sold.

Susquehanna International Group first reported a position in CDLX in Q3 2019 and held it in 24 quarters. The position peaked at $4.22M in Q4 2020. 43 funds tracked by Wall St. Rank hold CDLX as of Q2 2026.

  • Susquehanna International Group reported no remaining Cardlytics position as of Q2 2026 after selling out during the quarter.
  • Susquehanna International Group sold 1,592 Cardlytics shares in Q2 2026, an estimated $11.9K.
  • Susquehanna International Group first reported a position in Cardlytics in Q3 2019 and held it in 24 quarters.
  • Susquehanna International Group's Cardlytics position peaked at $4.22M in Q4 2020.
  • 43 funds tracked by Wall St. Rank held Cardlytics as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.